XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders’ Equity [Abstract]  
Schedule of stock options
   Shares   Weighted
Average
Exercise Price
   Weighted
Average
Contractual Term
Outstanding
   Intrinsic
Value
 
Outstanding at December 31, 2021   28,415,000   $0.1859    5.84   $50,673,665 
Granted   1,390,000   $2.400    9.76    (437,850)
Exercised   
-
   
-
           
Forfeited or expired   (7,000,000)   
-
         (14,595,000)
Outstanding at March 31, 2022   22,805,000   $0.3362    7.12   $39,880,525 
                     
Outstanding and exercisable at March 31, 2022   19,318,888   $0.1528    6.79   $37,328,593 

 

Schedule of black-scholes- merton option-pricing model applying the assumptions
   Three-months Ended
March 31,
 
   2022   2021 
Assumptions:        
Risk-free interest rate   1.26-1.30%   0%
Expected dividend yield   0%   0%
Expected volatility   126%   0%
Expected life (in years)   5    0 

 

   Three-months Ended
March 31,
 
   2022   2021 
Assumptions:        
Risk-free interest rate   0%   0%
Expected dividend yield   0%   0%
Expected volatility   0%   0%
Expected life (in years)   0    0 
Schedule of fair value of restricted stock and restricted stock units
   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
         
Outstanding at December 31, 2021   215,000   $             0.52 
Granted – restricted stock units and awards   
-
    
-
 
Granted – performance based stock units   
-
      
Canceled   
-
      
Vested and converted to shares   
-
      
Outstanding at March 31, 2022   215,000   $0.52 

 

Schedule of unrecognized stock-based compensation related to a lockup agreement
   Warrant Activity 
   Shares   Weighted Average
Exercise Price
   Weighted Average remaining Contractual Term (years) 
Outstanding at December 31, 2021   1,775,000   $0.0599    7.43 
Granted   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Forfeited   
-
    
-
    
-
 
Outstanding and exercisable at March 31, 2022   1,775,000   $0.0599    7.19 

 

Schedule of range exercise prices warrants outstanding and exercisable
   Warrants Outstanding   Warrants Exercisable 
Range of Exercise Prices  Shares
Outstanding
   Weighted
Avg.
Remaining
Contractual
Life in Years
   Weighted Avg.
Exercise Price
   Shares
Exercisable
   Weighted Avg.
Exercise Price
 
$0.05 - $0.08   1,775,000    7.19   $0.0599    1,775,000   $0.0599 
    1,775,000    7.19   $0.0599    1,775,000   $0.0599